Goldman Myla Lai
EVP & Chief Medical Officer, LabCorp.
Companies
- Quanterix (United States)Board member Jul 9, 2025 to now1
- Akoya Biosciences, Inc.Board member Sep 20, 2021 to now2
- West Pharmaceutical Services (United States)Board member Feb 21, 2014 to now3
- SequenomBoard member Sep 13, 2012 to Sep 7, 20164
- LabCorpEVP & Chief Medical Officer Jan 9, 2006 to Nov 24, 20085
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
West Pharmaceutical Services (United States) WST20,435 shares6$7.9M at $384.40May 4, 2026
Quanterix (United States) QTRX15,041 shares7$41.9K at $2.79Jul 8, 2026- Akoya Biosciences, Inc.0 shares8Jul 8, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 8, 2026Exercised options 8,073 shares of Quanterix (United States)7
- May 4, 2026Granted 791 shares of West Pharmaceutical Services (United States)6
- Jan 2, 2026Granted 1,944 shares of Quanterix (United States)9
- Jan 2, 2026Granted 23,372 shares of Quanterix (United States)9
- Oct 1, 2025Granted 2,084 shares at $5.54 of Quanterix (United States)10
- Jul 8, 2025Granted 24,464 shares of Quanterix (United States)11
- Jul 8, 2025Granted 2,940 shares of Quanterix (United States)11
- Jul 8, 2025Other 20,000 shares of Akoya Biosciences, Inc.8
- May 6, 2025Granted 1,071 shares of West Pharmaceutical Services (United States)12
- Apr 23, 2024Granted 564 shares of West Pharmaceutical Services (United States)13
- Jun 12, 2023Bought 20,000 shares at $5.00 of Akoya Biosciences, Inc.14
- Apr 25, 2023Granted 616 shares of West Pharmaceutical Services (United States)15
- May 24, 2022Granted 632 shares of West Pharmaceutical Services (United States)16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARSequenom, Board member
- 5SEC EDGARLabCorp, EVP & Chief Medical Officer
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jan 6, 2026
- 10SEC EDGARForm 4 filed Oct 3, 2025
- 11SEC EDGARForm 4 filed Jul 10, 2025
- 12SEC EDGARForm 4 filed May 8, 2025
- 13SEC EDGARForm 4 filed Apr 25, 2024
- 14SEC EDGARForm 4 filed Jun 12, 2023
- 15SEC EDGARForm 4 filed Apr 27, 2023
- 16SEC EDGARForm 4 filed May 26, 2022